163 related articles for article (PubMed ID: 10818680)
1. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms.
Ghia P; Caligaris-Cappio F
Adv Cancer Res; 2000; 79():157-73. PubMed ID: 10818680
[TBL] [Abstract][Full Text] [Related]
2. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
Granziero L; Circosta P; Scielzo C; Frisaldi E; Stella S; Geuna M; Giordano S; Ghia P; Caligaris-Cappio F
Blood; 2003 Mar; 101(5):1962-9. PubMed ID: 12406905
[TBL] [Abstract][Full Text] [Related]
3. Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas.
Taylor ST; Hickman JA; Dive C
Endocr Relat Cancer; 1999 Mar; 6(1):21-3. PubMed ID: 10732782
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
5. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
6. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
8. CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells.
Ribeiro P; Renard N; Warzocha K; Charlot C; Jeandenant L; Callet-Bauchu E; Coiffier B; Salles G
Br J Haematol; 1998 Dec; 103(3):684-9. PubMed ID: 9858217
[TBL] [Abstract][Full Text] [Related]
9. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
[TBL] [Abstract][Full Text] [Related]
10. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
[TBL] [Abstract][Full Text] [Related]
11. Mutations in apoptosis genes: a pathogenetic factor for human disease.
Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
[TBL] [Abstract][Full Text] [Related]
12. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
13. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.
Rathmell JC; Townsend SE; Xu JC; Flavell RA; Goodnow CC
Cell; 1996 Oct; 87(2):319-29. PubMed ID: 8861915
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
15. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
Kitada S; Zapata JM; Andreeff M; Reed JC
Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
[TBL] [Abstract][Full Text] [Related]
17. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
18. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.
Léveillé C; Zekki H; Al-Daccak R; Mourad W
Int Immunol; 1999 May; 11(5):719-30. PubMed ID: 10330277
[TBL] [Abstract][Full Text] [Related]
19. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
